Learn More
  • Bob Munk
  • Positively aware : the monthly journal of the…
  • 1997
T cell counts played a major role in monitoring HIV progression and treatment prior to the development of viral load testing. Drugs now being prescribed not only reduce viral load, but frequently cause a rebound in T cell counts. The role of T cells is described. Research is underway to address the question of whether preventive medication is necessary once(More)
  • Bob Munk
  • Positively aware : the monthly journal of the…
  • 1997
While some HIV-positive patients see no need to practice safe sex with positive partners, physicians are cautioning them that this practice is dangerous. Partners may be infecting each other with different drug-resistant strains of HIV, as well as exposing each other to a number of sexually transmitted diseases and opportunistic infections. These other(More)
  • Bob Munk
  • Positively aware : the monthly journal of the…
  • 1997
People who take protease inhibitors are beginning to report strange physical changes, including breast enlargement and accumulations of fat in the upper back and stomach. Although there is no evidence linking these changes to any particular drug, the symptoms are being referred to as Crix belly, from Crixivan, the most popularly prescribed protease(More)
  • Bob Munk
  • Positively aware : the monthly journal of the…
  • 1997
Clinical resistance, phenotypic resistance, genotypic resistance, and drug resistance are a few of the terms used to define resistance. Drug resistance refers to HIV's ability to live and multiply even when it is exposed to a lethal dose of antiviral drugs. Clinical resistance occurs when a patient's HIV disease gets worse despite using medications that are(More)